REFERENCES
- Goupil R, Brachemi S, Nadeau-Fredette AC, . Lymphopenia and treatment-related infectious complications in ANCA-associated vasculitis. Clin J Am Soc Nephrol. 2013;8(3):416–423.
- Mukhtyar C, Guillevin L, Cid MC, . European Vasculitis Study Group. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis. 2009;68(3):310–317.
- Eisenberger U, Fakhouri F, Vanhille P, . ANCA-negative pauci-immune renal vasculitis: histology and outcome. Nephrol Dial Transplant. 2005;20(7):1392–1399.
- Miller A, Chan M, Wiik A, Misbah SA, Luqmani RA. An approach to the diagnosis and management of systemic vasculitis. Clin Exp Immunol. 2010;160(2):143–160.
- Umeki S, Adachi M, Watanabe M, . Gabexate as a therapy for disseminated intravascular coagulation. Arch Intern Med. 1988;148:1409–1412.
- Gross WL, Schmitt WH, Csernok E. ANCA and associated diseases: immunodiagnostic and pathogenetic aspects. Clin Exp Immunol. 1993;91:1–12.
- Nakatani K, Takeshita S, Tsujimoto H, Kawamura Y, Sekine I. Inhibitory effect of serine protease inhibitors on neutrophil-mediated endothelial cell injury. J Leukoc Biol. 2001;69:241–247.
- Aosasa S, Ono S, Mochizuki H, Tsujimoto H, Ueno C, Matsumoto A. Mechanism of the inhibitory effect of protease inhibitor on tumor necrosis factor alpha production of monocyte. Shock. 2001;15:101–105.
- Saito T, Tsuchiya M, Shikata C, . Microscopic polyangiitis associated with marked systemic bleeding tendency caused by disseminated intravascular coagulation. Intern Med. 2003;42(9):850–855.
- Miyawaki K, Shiraishi J, Tsutsumi Y, . Beneficial effect of gabexate mesylate on microscopic polyangiitis with renal dysfunction and pulmonary hemorrhage: a case report. Angiology. 2006;57(4):522–525.